US Earnings to Watch: Pfizer, Qualcomm, CVS, Peloton, Coinbase, Uber

  • 📰 crypto
  • ⏱ Reading Time:
  • 11 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 63%

Switzerland Nachrichten Nachrichten

Switzerland Neuesten Nachrichten,Switzerland Schlagzeilen

These are the earnings — and stocks — to watch the week of Oct. 31

at this point in the second-quarter reporting season. Bottom-line misses also rose to 22% from 20% a quarter ago.

Qualcomm’s report later next week will put chipmakers’ resilience to test against the backdrop of faltering demand, while Pfizer will shed light on Covid-related revenues at a time when the pandemic recedes.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

 /  🏆 292. in CH
 

Vielen Dank für Ihren Kommentar.Ihr Kommentar wird nach Prüfung veröffentlicht.

yea!

Amazing! I have recently started using ChiefraFba for signals, his accuracy is INSANE!

Switzerland Neuesten Nachrichten, Switzerland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Peloton tells members it will no longer use Kanye West's music in new classes | CNN BusinessPeloton has 'indefinitely paused' playing Kanye West's music from its streaming workout classes. Bet they’ll still let you play R. Kelly tho… That sounds like a jew company. They probably don't even want people to buy their products unless they're jews. The woke Peloton is soontobehistory.
Herkunft: mynbc15 - 🏆 262. / 63 Weiterlesen »

Dow ends over 800 points higher as stocks cap a volatile week with big gainsU.S. stocks ended sharply higher Friday, capping a volatile week that saw Big Tech shares hammered after a series of disappointing earnings reports. The DJIA ended with a gain of around 828 points, or 2.6%, near 32,861, according to preliminary figures.
Herkunft: MarketWatch - 🏆 3. / 97 Weiterlesen »